Premier Biomedical Inc (BIEI)

[animaljive]

Why pump in that manner? There are a myriad of other companies with very low debt and similar market cap that have similar products in Phase 2, there's no logical reason for a company to buy this company out. Someone would have to offer them 100x their current market cap for it to make sense to Mr. Hartman, and even then I think he would be bummed out. They currently have a less than 8% chance of the drug referenced today to make it to market.

The painkiller market is where they see their actual profit coming from to generate the capital necessary to fund the immunotherapy products that is 4-6 years out from potentially generating a dollar.

Partnership for joint venture should be announced within the next week or so.